Abstract Details

<< Back to Detailed Agenda

9/24/2018  |   2:15 PM - 2:45 PM   |  Diamond Ballroom I

The Utah Cytomegalovirus (CMV) Mandate: A Five Year Review

In 2013 Utah became the first state in the nation to mandate hearing-directed cytomegalovirus (CMV) testing for all infants who fail the “newborn hearing screening test(s)” before 21 days of age. The rule written to accompany the law clarified eligibility by stating that eligible infants are those who fail both the initial hearing screen routinely done at birth and the subsequent follow-up screen OR when the initial failed hearing screen is obtained after 14 days of age. There was also a clause pertaining to Special Populations of Newborns whom testing for CMV is left to the discretion of the medical practitioner(s) caring for the newborn. These different eligibility categories, ever-evolving protocols, along with large data collection and stakeholder education needs all contributed to what seemed like daunting tasks within our program at times, yet five years later, 95% of eligible infants are receiving CMV testing. Come learn challenges we faced and how we overcame them; preliminary outcomes; and strategies for a successful newborn hearing screening-targeted CMV testing program.

  • Describe issues that can arise with non-univeral CMV testing mandates
  • Identify preliminary outcomes of the Utah CMV mandate
  • Create strategies for successful CMV testing programs

Presentation:
This presentation has not yet been uploaded.

Handouts:
No handouts have been uploaded.


Stephanie Browning McVicar (POC-Point of Contact,Primary Presenter,Author), smcvicar@utah.gov;
Dr. Stephanie Browning McVicar is the Director of the Early Hearing Detection and Intervention, Children’s Hearing Aid, and Cytomegalovirus Public Education & Testing Programs in Utah. She is a Program Manager in the Utah Department of Health's Children with Special Health Care Needs Bureau in Salt Lake City. She is the Director of the Infant-Pediatric Audiology Program for the URLEND (Utah Regional Leadership Education in Neurodevelopmental Disabilities) Program, training future leaders in transdisciplinary family-centered care of children and adolescents with special healthcare needs. Dr. McVicar is a pediatric audiologist, an advocate for CMV testing in newborns, and passionate about the prevention of congenital CMV infection. She is originally from Western New York and has extensive experience and knowledge in Audiology and the management of health care programs in both the public and private sectors. Dr. McVicar serves on the Board of Ethics for the American Speech-Language-Hearing Association.

      ASHA DISCLOSURE:

Financial - No relevant financial relationship exists.

Nonfinancial - No relevant nonfinancial relationship exists.


      AAA DISCLOSURE:

Financial - No relevant financial relationship exists.




Jill Boettger (Co-Presenter,Author), jboettge@utah.gov;
Jill has been a clinical provider at the Utah Department of Health's Children with Special Healthcare Needs Bureau for almost thirty years. Specializing in pediatrics and difficult-to-test populations, she has provided her expertise at Neonatal Follow-Up, Child Development, Children’s Hearing & Speech, and Itinerant Clinics throughout Utah. Jill is dually certified as an Audiologist and Speech-Language Pathologist. A valuable member of the Utah EHDI team, Jill conducts provider outreach, tracks referral and testing, and analyzes data for the Utah Cytomegalovirus (CMV) Public Health Initiative.

      ASHA DISCLOSURE:

Financial - No relevant financial relationship exists.

Nonfinancial - No relevant nonfinancial relationship exists.


      AAA DISCLOSURE:

Financial - No relevant financial relationship exists.